4
Changes in Ownership
Intellia Therapeutics, Inc. Filed Acc 0000950170-25-032192
EVP, Chief Financial Officer acquired 47,200 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dulac Edward J III EVP, Chief Financial Officer | 2025-03-01 | Grant or award | +47,200 | 113,524 | D | ||
| Derivatives | |||||||
| Dulac Edward J III EVP, Chief Financial Officer | 2025-03-01 | Grant or award · Stock Option (right to buy) | +67,429 | 67,429 | D | ||
Loading xslF345X05/ownership.xml…